The 4-HPR used with survivin knockdown, an overexpressed pro survival protein in GBM, in around 80% of cells were apoptotic and reduced tumor vascularization, as revealed by in vivo angiogenesis studies. The gene discussed is BIRC5; the disease is glioblastoma.